High Serum Adipocyte Fatty Acid Binding Protein Is Associated with Metabolic Syndrome in Patients with Type 2 Diabetes

Table 2

Clinical characteristics and fasting serum adipocyte fatty acid binding protein levels of 165 diabetic patients.

Characteristic		Number (%)	A-FABP (ng/mL)	value
Gender	Male	92 (55.7)	23.90 ± 12.44	<0.001
	Female	73 (44.3)	34.27 ± 17.16
Hypertension	No	79 (47.9)	26.16 ± 15.49	0.065
	Yes	86 (52.1)	30.63 ± 15.38
Smoking	No	148 (89.7)	28.54 ± 15.55	0.907
	Yes	17 (10.3)	28.07 ± 16.03
Statin	No	84 (50.9)	26.83 ± 13.07	0.164
	Yes	81 (49.1)	30.21 ± 17.68
Fibrate	No	156 (94.5)	28.14 ± 15.73	0.229
	Yes	9 (5.5)	34.57 ± 10.78
Metformin	No	74 (44.8)	28.47 ± 16.54	0.986
	Yes	91 (55.2)	28.51 ± 14.79
Sulfonylureas	No	77 (46.7)	29.07 ± 16.50	0.654
	Yes	88 (53.3)	27.98 ± 14.75
DDP-4 inhibitor	No	65 (39.4)	28.03 ± 17.09	0.763
	Yes	100 (60.6)	28.79 ± 14.54
Thiazolidinediones	No	160 (97.0)	28.26 ± 14.60	0.282
	Yes	5 (3.0)	35.88 ± 37.05
Insulin	No	122 (73.9)	28.39 ± 15.68	0.887
	Yes	43 (26.1)	28.78 ± 15.34

Data are expressed as means ± standard deviations.
was considered statistically significant after Student’s -test.
DDP-4, dipeptidyl peptidase 4.